BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 33963696)

  • 1. Contralateral Prophylactic Mastectomy in Patients with Breast Cancer.
    Noditi A; Caragheorghe G; Stoleru S; Blidaru A; Bordea CI
    Chirurgia (Bucur); 2021; 116(2 Suppl):73-83. PubMed ID: 33963696
    [No Abstract]   [Full Text] [Related]  

  • 2. Bilateral prophylactic mastectomy in BRCA mutation carriers: what surgeons need to know.
    Franceschini G; Di Leone A; Terribile D; Sanchez MA; Masetti R
    Ann Ital Chir; 2019; 90():1-2. PubMed ID: 30872561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of contralateral prophylactic mastectomy and the impact on breast reconstruction.
    Pinell-White XA; Kolegraff K; Carlson GW
    Ann Plast Surg; 2014; 72(6):S153-7. PubMed ID: 24691345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rate of contralateral prophylactic mastectomy is influenced by preoperative MRI recommendations.
    Xia C; Schroeder MC; Weigel RJ; Sugg SL; Thomas A
    Ann Surg Oncol; 2014 Dec; 21(13):4133-8. PubMed ID: 24934585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contralateral prophylactic mastectomy in an Asian population: a single institution review.
    Sim Y; Tan VK; Ho GH; Wong CY; Madhukumar P; Tan BK; Yong WS; Ng YY; Ong KW
    Breast; 2014 Feb; 23(1):56-62. PubMed ID: 24275318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in Contralateral Prophylactic Mastectomy.
    Fairbairn K; Cervantes A; Rayhrer C; Steen S
    Aesthetic Plast Surg; 2020 Apr; 44(2):323-329. PubMed ID: 31853610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tradeoffs Associated With Contralateral Prophylactic Mastectomy in Women Choosing Breast Reconstruction: Results of a Prospective Multicenter Cohort.
    Momoh AO; Cohen WA; Kidwell KM; Hamill JB; Qi J; Pusic AL; Wilkins EG; Matros E
    Ann Surg; 2017 Jul; 266(1):158-164. PubMed ID: 27355266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of patient characteristics and outcomes of contralateral prophylactic mastectomy and unilateral total mastectomy in breast cancer patients.
    Chung A; Huynh K; Lawrence C; Sim MS; Giuliano A
    Ann Surg Oncol; 2012 Aug; 19(8):2600-6. PubMed ID: 22396004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The financial impact and drivers of hospital charges in contralateral prophylactic mastectomy and reconstruction: a Nationwide Inpatient Sample hospital analysis.
    Bucknor A; Chattha A; Ultee K; Wu W; Kamali P; Bletsis P; Chen A; Lee BT; Cronin C; Lin SJ
    Breast Cancer Res Treat; 2017 Sep; 165(2):301-310. PubMed ID: 28634720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing the additional surgical risk of contralateral prophylactic mastectomy and immediate breast implant reconstruction.
    Nealon KP; Sobti N; Gadd M; Specht M; Liao EC
    Breast Cancer Res Treat; 2020 Jan; 179(2):255-265. PubMed ID: 31605310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of genetic counseling on the uptake of contralateral prophylactic mastectomy among younger women with breast cancer.
    Terkelsen T; Rønning H; Skytte AB
    Acta Oncol; 2020 Jan; 59(1):60-65. PubMed ID: 31379231
    [No Abstract]   [Full Text] [Related]  

  • 12. Association of Moderate-Risk Breast Cancer Genes with Contralateral Prophylactic Mastectomy and Bilateral Disease.
    Zhang JQ; Dos Anjos CH; Sevilimedu V; Crown A; Amoroso KA; Pilewskie ML; Robson ME; Gemignani ML
    Ann Surg Oncol; 2023 Nov; 30(12):6990-6999. PubMed ID: 37661222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growing Use of Contralateral Prophylactic Mastectomy Despite no Improvement in Long-term Survival for Invasive Breast Cancer.
    Wong SM; Freedman RA; Sagara Y; Aydogan F; Barry WT; Golshan M
    Ann Surg; 2017 Mar; 265(3):581-589. PubMed ID: 28169929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EBCC-13 manifesto: Balancing pros and cons for contralateral prophylactic mastectomy.
    Schmidt MK; Kelly JE; Brédart A; Cameron DA; de Boniface J; Easton DF; Offersen BV; Poulakaki F; Rubio IT; Sardanelli F; Schmutzler R; Spanic T; Weigelt B; Rutgers EJT
    Eur J Cancer; 2023 Mar; 181():79-91. PubMed ID: 36641897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contralateral Prophylactic Mastectomy for Women with T4 Locally Advanced Breast Cancer.
    Murphy BL; Hoskin TL; Boughey JC; Degnim AC; Glazebrook KN; Hieken TJ
    Ann Surg Oncol; 2016 Oct; 23(10):3365-70. PubMed ID: 27364506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors for contralateral prophylactic mastectomy in breast cancer patients.
    Fu Y; Zhuang Z; Dewing M; Apple S; Chang H
    Int J Clin Exp Pathol; 2015; 8(4):3748-64. PubMed ID: 26097557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growing Trends of Contralateral Prophylactic Mastectomy and Reconstruction in Young Breast Cancer.
    Chen H; Zhang P; Zhang M; Wang M; Bai F; Wu K
    J Surg Res; 2019 Jul; 239():224-232. PubMed ID: 30856515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Issues of regret in women with contralateral prophylactic mastectomies.
    Montgomery LL; Tran KN; Heelan MC; Van Zee KJ; Massie MJ; Payne DK; Borgen PI
    Ann Surg Oncol; 1999 Sep; 6(6):546-52. PubMed ID: 10493622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical management factors contribute to the decision for contralateral prophylactic mastectomy.
    King TA; Sakr R; Patil S; Gurevich I; Stempel M; Sampson M; Morrow M
    J Clin Oncol; 2011 Jun; 29(16):2158-64. PubMed ID: 21464413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing the Effect of Lifetime Contralateral Breast Cancer Risk on the Selection of Contralateral Prophylactic Mastectomy for Unilateral Breast Cancer.
    Hegde JV; Wang X; Attai DJ; DiNome ML; Kusske A; Hoyt AC; Hurvitz SA; Weidhaas JB; Steinberg ML; McCloskey SA
    Clin Breast Cancer; 2018 Apr; 18(2):e205-e218. PubMed ID: 29050918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.